Word

ADIPOCHEM

Status

Dead

Status Code

710

Status Date

Friday, February 4, 2022

Serial Number

86246364

Registration Number

4780051

Registration Date

Tuesday, July 28, 2015

Mark Type

4000

Filing Date

Tuesday, April 8, 2014

Published for Opposition

Tuesday, May 12, 2015

Cancellation Date

Friday, February 4, 2022

Trademark Owner History

ADIPOGEN LIFE SCIENCES, INC. -
Adipogen International, Inc. - Original Registrant

Classifications

5 Biological preparations for diagnostic purposes; Chemical reagents for medical or veterinary purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of polyclonal and monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical purposes; Diagnostic reagents for medicinal use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids or cell cultures; Medical diagnostic reagents; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of obesity and diabetes and inflammatory disorders, for use in angiogenesis, dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and natural medicinal extracts derived from animal, plant and microorganism sources for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, obesity and diabetes, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Reagents and media for medical diagnostic and veterinary diagnostic purposes; Antibiotics for research purposes

35 on-line retail store services featuring life science reagents; providing consumer product pricing information, and original manufacturers' information on product pricing to purchasing organizations and individual life science customers featuring life science reagents provided via an online computer network

1 Assays for research purposes; Biochemical and chemical reagents for research purposes; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Biochemicals, namely, polypeptides for in vitro research use; Biomedical compounds, namely, peptide substrates used in analyzing and detecting enzymes and proteins for laboratory or research use; Chemicals for use in the purification of proteins for in vitro use; Diagnostics, namely, diagnostic preparations and reagents other than for medical or veterinary purposes; Diagnostic preparations and reagents for scientific or research use; Diagnostic preparations and reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Protein arrays and nucleotide arrays for scientific and medical research; Reagent for chemical analyses; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis; Stem cell reagents for research purposes; Testing kits containing peptide substrates used in analyzing and detecting proteins, enzymes and receptors for laboratory or research use; Testing kits containing peptide substrates used in analyzing and detecting proteins, enzymes and receptors for clinical or medical laboratory use

ADIPO CHEM

Trademark Events

Feb 4, 2022

Cancelled Sec. 8 (6-Yr)

Jul 28, 2020

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Aug 9, 2017

Automatic Update Of Assignment Of Ownership

Jul 28, 2015

Registered-Principal Register

May 12, 2015

Official Gazette Publication Confirmation E-Mailed

May 12, 2015

Published For Opposition

Apr 22, 2015

Notification Of Notice Of Publication E-Mailed

Apr 3, 2015

Law Office Publication Review Completed

Apr 1, 2015

Approved For Pub - Principal Register

Mar 31, 2015

Examiner's Amendment Entered

Mar 31, 2015

Notification Of Examiners Amendment E-Mailed

Mar 31, 2015

Examiners Amendment E-Mailed

Mar 31, 2015

Examiners Amendment -Written

Jan 23, 2015

Notification Of Final Refusal Emailed

Jan 23, 2015

Final Refusal E-Mailed

Jan 23, 2015

Final Refusal Written

Jan 17, 2015

Teas/Email Correspondence Entered

Jan 16, 2015

Correspondence Received In Law Office

Jan 16, 2015

Teas Response To Office Action Received

Jul 16, 2014

Combined Examiner's Amendment/Priority Action Entered

Jul 16, 2014

Assigned To Lie

Jul 16, 2014

Notification Of Examiner's Amendment/Priority Action E-Mailed

Jul 16, 2014

Examiner's Amendment/Priority Action E-Mailed

Jul 16, 2014

Examiners Amendment And/Or Priority Action - Completed

Jul 16, 2014

Assigned To Examiner

Apr 23, 2014

Notice Of Pseudo Mark E-Mailed

Apr 22, 2014

New Application Office Supplied Data Entered In Tram

Apr 11, 2014

New Application Entered In Tram